Axsome Therapeutics, Inc. Share Price
NASDAQ: AXSM | Mid CapAxsome Therapeutics, Inc. Stock Performance
Axsome Therapeutics, Inc. Share Price Today
As of 30 October 2026, Axsome Therapeutics, Inc.'s share price is $143.56. The stock opened at $146.45, compared to its previous close of $143.48. During today's trading session, Axsome Therapeutics, Inc.'s share price traded between $140.43 and $146.69, with an average price of $143.56. Over the past 52 weeks, the stock has recorded a high of $257.81 and a low of $124.00. In terms of performance, Axsome Therapeutics, Inc.'s share price has declined by 30.98% over the last six months and is up 6.21% on a year-on-year basis.
Axsome Therapeutics, Inc. Share Price Chart
Axsome Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Axsome Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Axsome Therapeutics, Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Axsome Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $185.01 | $143.55 | -22.24% |
Sep 2026 | $202.30 | $184.60 | -10.51% |
Aug 2026 | $216.00 | $206.28 | -5.35% |
Jul 2026 | $245.96 | $217.94 | -10.99% |
Jun 2026 | $233.13 | $244.85 | +4.41% |
May 2026 | $208.59 | $234.52 | +12.75% |
Apr 2026 | $171.42 | $208.00 | +23.22% |
Mar 2026 | $162.50 | $168.80 | +3.00% |
Feb 2026 | $184.79 | $163.89 | -11.07% |
Jan 2026 | $182.32 | $184.30 | +0.85% |
Dec 2025 | $150.63 | $182.74 | +20.69% |
Nov 2025 | $124.75 | $151.41 | +12.01% |